【ScinoPharm】Important Resolutions of the 115 Annual General Shareholders' Meeting
ScinoPharm held its Annual General Shareholders' Meeting on May 27, 115, approving a cash dividend of 0.29 TWD per share for the 114 fiscal year. The meeting also passed amendments to the Articles of Incorporation, asset disposal procedures, and the lifting of non-compete restrictions for directors.
📋 Article Processing Timeline
- 📰 Published: May 27, 2026 at 09:00
- 🔍 Collected: May 28, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 31, 2026 at 18:51 (82h 51m after Collected)
1. Date of AGM: 115/05/27. 2. Earnings distribution: Approved the 114 earnings distribution plan, with a cash dividend of 0.29 TWD per share. 3. Articles of Incorporation: Approved amendments. 4. Business report and financial statements: Approved the 114 business report and financial statements. 5. Election of directors/supervisors: None. 6. Other matters: (1) Approved amendments to the 'Procedures for Acquisition or Disposal of Assets'. (2) Approved the lifting of non-compete restrictions for directors (including independent directors) and their representatives. 7. Other notes: None.
FAQ
When will the dividends be paid?
The specific payment date will be announced separately by the company.
What does lifting non-compete restrictions mean?
It allows directors to hold positions in other companies, facilitating broader industry collaboration.